Chinese firm to acquire biologics substance facility in Germany from Bayer

Chinese firm to acquire biologics substance facility in Germany from Bayer
WESPECH PTE LTD
8 Eu Tong Sen Street #14-94, The Central, Singapore (059818)
+65 315 904 24

22.12.2020

MOSCOW (MRC) -- Bayer is selling a biologics substance facility at the company's Wuppertal, Germany, site part of its pharmaceuticals division to a German subsidiary of biopharmaceutical company WuXi Biologics (Wuxi, China), said Chemweek.Under the agreement, the two companies will also enter into a long-term sublease agreement and a transitional service contract. WuXi Biologics intends t

Full article at mrcplast.com

Back

news